Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Reuven Reich is active.

Publication


Featured researches published by Reuven Reich.


Biochemical and Biophysical Research Communications | 1989

Eicosapentaenoic acid reduces the invasive and metastatic activities of malignant tumor cells

Reuven Reich; Leah S. Royce; George R. Martin

Recent studies have shown that the cyclooxygenase and the 5-lipoxygenase pathways of arachidonic acid, are required for the invasive and metastatic activity of certain tumor cells. We show here that malignant murine melanoma and human fibrosarcoma cells cultured in media supplemented with eicosapentaenoic acid show a dose and time dependent decrease in invasiveness, in collagenase IV production and in the case of the murine cells, a reduced ability to metastasize to the lung after intravenous injection. It was also shown that a metabolite of eicosapentaenoic acid was less potent than the comparable arachidonic acid metabolite in restoring collagenase IV production and invasiveness after inhibition of the lipoxygenase pathway. These studies indicate that such supplements have the potential to reduce the metastasis of certain tumor cells, converting them to benign status.


Clinical & Experimental Metastasis | 1993

Cyclic AMP decreases chemotaxis, invasiveness and lung colonization of H-ras transformed mouse fibroblasts

Yukihide Iwamoto; Reuven Reich; Gabor G. Nemeth; Yoshihiko Yamada; George R. Martin

We transfected mouse 10T1/2 fibroblasts with the H-ras oncogene and isolated lines expressing H-ras. One of the lines exhibited a highly malignant phenotype with the ability to produce large tumors and to colonize the lung after tail vein injection. In addition, the cells of this line showed increased collagenase IV production, directed migration and invasiveness, properties associated with the ability of tumor cells to metastasize. Since cyclic adenosine 3′,5′-monophosphate (cAMP) is known to down-regulate ras expression, we exposed the malignant cells (Cl-1) to either N6, 2′,0-dibutyryl cAMP (DB-cAMP) or 8-bromo cAMP (8-Br-cAMP), either with or without a phosphodiesterase inhibitor. We found that these treatments reduced the expression of ras, chemotaxis, invasiveness, and lung colonization of the ras-transformed cells. We therefore postulate that the malignancy of some cells may be regulated by alterations in the intracellular cAMP levels by suppressing ras expression and/or by reducing other activities required for the dissemination of tumor cells.


Cancer treatment and research | 1988

Factors regulating basement membrane invasion by tumor cells.

Erik W. Thompson; Reuven Reich; George R. Martin; Adriana Albini

Basement membranes serve as significant barriers to the passage of tumor cells but ones which metastatic cells can pass. This involves the production of a cascade of proteases leading to the activation of a specific collagenase that degrades the unique collagen network in basement membrane. Breast cancer cells, when estrogen dependent, show a requirement for estrogen for invasive activity. However, when these cells progress to an estrogen independent state and increased malignancy, they express an invasive phenotype constitutively. Studies with various anti-estrogens suggest that these responses are mediated via the estrogen receptor. Anti-estrogens lacking agonist activity suppress invasiveness as well as growth of the breast cancer cells.


Cancer Research | 1988

Differential Regulation of Growth and Invasiveness of MCF-7 Breast Cancer Cells by Antiestrogens

Erik W. Thompson; Reuven Reich; Thomas B. Shima; Adriana Albini; Jeannette Graf; George R. Martin; Robert B. Dickson; Marc E. Lippman


Journal of the National Cancer Institute | 1989

Invasive and Metastatic Potential of a v-Ha-ras-Transformed Human Bronchial Epithelial Cell Line

R. Daniel Bonfil; Roger R. Reddel; Hitoshi Ura; Reuven Reich; Rafael Fridman; Curtis C. Harris; Andres J. Klein-Szanto


Journal of Cellular Physiology | 1990

Differential effects of phorbol ester on the in vitro invasiveness of malignant and non-malignant human fibroblast cells

Rafael Fridman; Juan Carlos Lacal; Reuven Reich; Daniel R. Bonfil; Chang Ho Ahn


Carcinogenesis | 1989

Enhancement of the invasive ability of a transformed human bronchial epithelial cell line by 12-O-tetra-decanoyl-phorbol-13-acetate and diacylglycerol

R. Daniel Bonfil; Shigeru Momiki; Rafael Fridman; Reuven Reich; Roger R. Reddel; Curtis C. Harris; Andres Klien-Szanto


Ciba Foundation Symposium 141 - Metastasis | 2007

Inhibitors of Collagenase IV and Cell Adhesion Reduce the Invasive Activity of Malignant Tumour Cells

Reuven Reich; Bridget Stratford; Karen Oerter Klein; George R. Martin; Richard A. Mueller; George C. Fuller


Archive | 1989

Heterocyclic amides to inhibit tumor metastasis

George Reilly Martin; Richard A. Mueller; Reuven Reich; George C. Fuller


Archive | 1989

Verwendung heterozyklischer Amide zur Verhinderung der Tumormetastasierung. Use of heterocyclic amides for preventing tumor metastasis.

George C. Fuller; George Reilly Martin; Richard A. Mueller; Reuven Reich

Collaboration


Dive into the Reuven Reich's collaboration.

Top Co-Authors

Avatar

George R. Martin

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Erik W. Thompson

Queensland University of Technology

View shared research outputs
Top Co-Authors

Avatar

Adriana Albini

National Cancer Research Institute

View shared research outputs
Top Co-Authors

Avatar

Rafael Fridman

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Roger R. Reddel

Children's Medical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Curtis C. Harris

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jeannette Graf

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert B. Dickson

Georgetown University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge